• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一项关于在儿童院前急性行为障碍中使用氟哌利多的安全性和有效性的前瞻性研究。

A Prospective Study of the Safety and Effectiveness of Droperidol in Children for Prehospital Acute Behavioral Disturbance.

出版信息

Prehosp Emerg Care. 2019 Jul-Aug;23(4):519-526. doi: 10.1080/10903127.2018.1542473. Epub 2018 Dec 7.

DOI:10.1080/10903127.2018.1542473
PMID:30380965
Abstract

Although uncommon, children (<16 years) with acute behavioral disturbance are a significant issue for emergency medical service providers. In this study, we aimed to investigate the safety and effectiveness of droperidol in children with prehospital acute behavioral disturbance. This was a prospective observational study over 1 year investigating the use of droperidol (0.1-0.2 mg/kg) for children (< 16 years) with acute behavioral disturbance. Inclusion criteria for acute behavioral disturbance were defined by a sedation assessment tool score of ≥2 determined by the attending paramedic. The primary outcome was the proportion of adverse effects (need for airway intervention, oxygen saturation <90% and/or respiratory rate <12, systolic blood pressure <90 mmHg, sedation assessment tool score of -3 and dystonic reactions). Secondary outcomes included time to sedation (sedation assessment tool score decreased by 2 or more, or a score of zero), requirement for additional sedation, failure to sedate and proportion of sedation success defined as the number of patients successfully sedated who did not suffer any adverse events or receive additional sedation. There were 96 patients (males 51 [53%], median age 14 years [range 7-15 years]) who presented on 102 occasions over the one year study period. Self-harm and/or harm to others was the commonest (74/105 [70%]) cause of acute behavioral disturbance followed by alcohol (16/105 [15%]). There were 9 adverse events in 8 patients (8/102 [8%]; 95% confidence intervals [CI]: 3-13%) Five patients had hypotension, all asymptomatic and only one required treatment; 2 dystonic reactions managed with benztropine and one patient with respiratory depression. Median time to sedation was 14 min (interquartile range (IQR): 10-20 min; range: 3-85 min). There was no requirement for prehospital additional sedation (0/102 [0%]; 95% CI: 0-4%) and additional sedation in the first hour of arrival to hospital was required by 4 patients (4/102 [4%]; 95% CI: 1-10%). Overall successful sedation was achieved in 89 (87%) patients. The use of droperidol in children for acute behavioral disturbance in the prehospital setting is both safe and effective.

摘要

虽然不常见,但患有急性行为障碍的儿童(<16 岁)是急诊医疗服务提供者面临的一个重大问题。在这项研究中,我们旨在调查在院前患有急性行为障碍的儿童中使用氟哌啶醇的安全性和有效性。 这是一项为期 1 年的前瞻性观察研究,调查了氟哌啶醇(0.1-0.2mg/kg)在急性行为障碍儿童中的应用。急性行为障碍的纳入标准定义为由值班护理人员确定的镇静评估工具评分≥2。主要结局是不良事件的比例(需要气道干预、氧饱和度<90%和/或呼吸频率<12、收缩压<90mmHg、镇静评估工具评分-3 和张力障碍反应)。次要结局包括镇静时间(镇静评估工具评分降低 2 或更多,或评分为 0)、需要额外镇静、镇静失败和镇静成功率的比例(成功镇静的患者数量,无不良事件或接受额外镇静)。 在为期 1 年的研究期间,共有 96 名患者(男性 51 名[53%],中位年龄 14 岁[范围 7-15 岁])在 102 次就诊中接受了治疗。自我伤害和/或伤害他人是最常见(74/105[70%])的急性行为障碍原因,其次是酒精(16/105[15%])。8 名患者(8/102[8%];95%置信区间[CI]:3-13%)出现 9 起不良事件。5 名患者出现低血压,均无症状,仅 1 名患者需要治疗;2 名张力障碍反应用苯海索治疗,1 名患者出现呼吸抑制。镇静中位时间为 14 分钟(四分位距(IQR):10-20 分钟;范围:3-85 分钟)。院前无需额外镇静(0/102[0%];95%CI:0-4%),102 名患者中 4 名(4/102[4%];95%CI:1-10%)在到达医院的第一个小时内需要额外镇静。89 名(87%)患者总体镇静成功。氟哌啶醇在院前环境中用于儿童急性行为障碍既安全又有效。

相似文献

1
A Prospective Study of the Safety and Effectiveness of Droperidol in Children for Prehospital Acute Behavioral Disturbance.一项关于在儿童院前急性行为障碍中使用氟哌利多的安全性和有效性的前瞻性研究。
Prehosp Emerg Care. 2019 Jul-Aug;23(4):519-526. doi: 10.1080/10903127.2018.1542473. Epub 2018 Dec 7.
2
A Prospective Before and After Study of Droperidol for Prehospital Acute Behavioral Disturbance.氟哌利多用于院前急性行为障碍的前瞻性前后对照研究。
Prehosp Emerg Care. 2018 Nov-Dec;22(6):713-721. doi: 10.1080/10903127.2018.1445329. Epub 2018 Mar 20.
3
Prospective study of the safety and effectiveness of droperidol in elderly patients for pre-hospital acute behavioural disturbance.前瞻性研究在院前急性行为障碍老年患者中使用氟哌利多的安全性和有效性。
Emerg Med Australas. 2020 Oct;32(5):731-736. doi: 10.1111/1742-6723.13496. Epub 2020 Mar 26.
4
The Safety and Effectiveness of Droperidol for Sedation of Acute Behavioral Disturbance in the Emergency Department.急诊科中氟哌利多用于急性行为障碍镇静的安全性与有效性
Ann Emerg Med. 2015 Sep;66(3):230-238.e1. doi: 10.1016/j.annemergmed.2015.03.016. Epub 2015 Apr 15.
5
Ketamine as a rescue treatment for severe acute behavioural disturbance: A prospective prehospital study.氯胺酮作为严重急性行为障碍的抢救治疗:一项前瞻性院前研究。
Emerg Med Australas. 2021 Aug;33(4):610-614. doi: 10.1111/1742-6723.13682. Epub 2020 Nov 17.
6
Parenteral sedation of elderly patients with acute behavioral disturbance in the ED.急诊老年急性行为障碍患者的肠外镇静。
Am J Emerg Med. 2013 Jun;31(6):970-3. doi: 10.1016/j.ajem.2013.03.026. Epub 2013 May 16.
7
Ketamine as Rescue Treatment for Difficult-to-Sedate Severe Acute Behavioral Disturbance in the Emergency Department.氯胺酮作为急诊科难以镇静的严重急性行为障碍的抢救治疗药物。
Ann Emerg Med. 2016 May;67(5):581-587.e1. doi: 10.1016/j.annemergmed.2015.11.028. Epub 2016 Feb 18.
8
A systematic review of the effectiveness and safety of droperidol for pediatric agitation in acute care settings.系统评价在急性医疗环境中使用氟哌利多治疗儿科激越的疗效和安全性。
Acad Emerg Med. 2022 Dec;29(12):1466-1474. doi: 10.1111/acem.14515. Epub 2022 May 22.
9
Droperidol v. haloperidol for sedation of aggressive behaviour in acute mental health: randomised controlled trial.氟哌啶醇与氟哌啶醇用于急性心理健康中激越行为的镇静:随机对照试验。
Br J Psychiatry. 2015 Mar;206(3):223-8. doi: 10.1192/bjp.bp.114.150227. Epub 2014 Nov 13.
10
Comparison of droperidol and haloperidol for use by paramedics: assessment of safety and effectiveness.护理人员使用氟哌利多和氟哌啶醇的比较:安全性和有效性评估。
Prehosp Emerg Care. 2014 Jul-Sep;18(3):375-80. doi: 10.3109/10903127.2013.864353. Epub 2014 Jan 24.

引用本文的文献

1
The epidemiology and phenomenology of non-antipsychotic-induced dystonia: a hybrid systematic-narrative review.非抗精神病药物所致肌张力障碍的流行病学与现象学:一项系统-叙述性混合综述
Eur Psychiatry. 2025 Feb 10;68(1):e36. doi: 10.1192/j.eurpsy.2025.18.
2
Parenteral medication for the management of acute severe behavioural disturbance (ASBD) in the emergency department.用于急诊科急性严重行为障碍(ASBD)管理的胃肠外用药
Cochrane Database Syst Rev. 2024 May 29;5(5):CD014826. doi: 10.1002/14651858.CD014826.
3
Emergency department mental health presentations in young children: a retrospective chart review.
幼儿急诊科心理健康就诊情况:一项回顾性病历审查
J Paediatr Child Health. 2024 Sep;60(9):415-421. doi: 10.1111/jpc.16600. Epub 2024 Jun 21.
4
Characteristics of pediatric behavioral health emergencies in the prehospital setting.院前环境下儿科行为健康紧急情况的特征
Acad Emerg Med. 2024 Feb;31(2):129-139. doi: 10.1111/acem.14833. Epub 2023 Nov 27.
5
Standardizing and Improving Care for Pediatric Agitation Management in the Emergency Department.规范和改进急诊科儿科激越管理的护理。
Pediatrics. 2023 Jul 1;152(1). doi: 10.1542/peds.2022-059586.
6
Prehospital Management of Pediatric Behavioral Health Emergencies: A Scoping Review.儿科行为健康紧急情况的院前管理:一项范围综述
Cureus. 2023 May 10;15(5):e38840. doi: 10.7759/cureus.38840. eCollection 2023 May.
7
Pharmacological emergency management of agitation in children and young people: protocol for a randomised controlled trial of oral medication (PEAChY-O).儿童和青少年激越的药理学紧急处理:口服药物(PEAChY-O)随机对照试验的方案。
BMJ Open. 2023 Mar 30;13(3):e067433. doi: 10.1136/bmjopen-2022-067433.
8
Pharmacological Emergency management of Agitation in Children and Young people: protocol for a randomised controlled trial of intraMuscular medication (PEAChY-M).儿童和青少年激越的药理学紧急处理:肌肉内药物(PEAChY-M)随机对照试验的方案。
BMJ Open. 2023 Mar 30;13(3):e067436. doi: 10.1136/bmjopen-2022-067436.
9
Management of paediatric acute severe behavioural disturbance in emergency departments across Australia: A PREDICT survey of senior medical staff.澳大利亚急诊科儿科急性严重行为障碍管理:资深医务人员的 PREDICT 调查。
Emerg Med Australas. 2023 Apr;35(2):254-260. doi: 10.1111/1742-6723.14105. Epub 2022 Nov 3.
10
A systematic review of the effectiveness and safety of droperidol for pediatric agitation in acute care settings.系统评价在急性医疗环境中使用氟哌利多治疗儿科激越的疗效和安全性。
Acad Emerg Med. 2022 Dec;29(12):1466-1474. doi: 10.1111/acem.14515. Epub 2022 May 22.